Báo cáo y học: "Annual Scientific Meeting, Edmonton, September 27–30, 2007" pot

... certain types ofcancers may have potential as adjuvant immunotherapy.Relationship between Metabolic Syndrome, Asthma,and Airway HyperresponsivenessN. Saurek-Aleksandrovska, A.L. Kozyrskyj, R. ... Allergy and Clinical Immunology, ClinicalEpidemiology, and Allergy and Clinical Immunology,McGill University Health Centre, Montreal, QC; Divisionof Allergy and Clinical Immunology, North York ... inhalation.Immunotherapy for Hymenoptera AllergyIan MacDougall, McMaster University, Hamilton, ONOver the past number of years immunotherapy forHymenoptera allergy has become an extremely effectivetreatment...

... VAMP-8 in CTLs and YT-Indy by Western blot analysis. VAMP-8 protein is notexpressed in YT-Indy. Confocal microscopy supporteddata of Western blot analysis in both CT Ls and YT-Indy. Conclusion: ... (91.5%),runny nose (82.4%), itchy/gritty eyes (80.4%), stuffiness(78.5%), itchy nose (71.3%), watery eyes (64.7%), itchypalate/throat (56.9%), post-nasal drip (55.6%), red/burning eyes (49.1%), ... all ninesymptoms (limitation of activities, sneezing, stuffynose, runny nose, watery eyes, itchy eyes, sleep impair-ment, fatigue, irritability) of 44% to 60% (p < .0001 forall symptoms)....

... Finland;2Department of Clinical Chemistry, TampereUniversity Hospital, Finland;3Department of Anatomy, University of Tampere, FinlandA differential display method was used to study genes theexpression of ... primary targetgene for progestins. Surprisingly, however, the proteinsynthesis inhibitor cycloheximide did not abolish theinduction, which suggested that GPR30 is directly regulatedby progestins. ... of cyclin-dependent kinaseinactivation by progestins. Mol. Cell. Biol. 18, 1812–1825.Fig. 3. GPR30 mRNA is upregulated by p38 inhibitor, but not alteredby the ERK1/ERK2 pathway. To study whether...

... over, the barrier may dominate thereaction pathway.SLO catalyzes the production of fatty acid hydroper-oxides at 1,4-pentadienyl positions, and the product 13-(S)-hydroperoxy-9,11-(Z,E)-octadecadienoic ... Proton and hydrogen atomtunnelling in hydrolytic and redox enzyme catalysis. Can. J. Chem.77, 1085–1096.16. Bell, R.P. (1980) The Tunnel Effect in Chemistry. Chapman &Hall,NewYork,NY.17. Su¨hnel, ... directly link enzyme fluctuations to thereaction coordinate for hydrogen transfer, making a quan-tum view of hydrogen transfer necessarily a dynamic view ofcatalysis. The environmentally coupled...

... University, Xi'an, 710032, China 3. Department of Oral Histology and Pathology, School of Stomatology, Fourth Military Medical University, Xi’an, 710032, China 4. Department of Stomatology, ... the CD14+ monocyte-derived progenitors but designated peripheral blood multipotential mesenchymal progenitors (PBMMPs). Phenotype analysis demonstrated expression of mesenchymal markers in ... class="bi x0 y0 w1 h1" alt="" src="data:image/png;base64,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....

... surgery would be extremelydifficult to demonstrate because the incidence ofserious complications is, fortunately, already verylow. Image-guided surgery has not yet, and maynever, become the standard ... (chronichyperplastic rhinosinusitis) but without polypo-sis and those patients with diffuse sinonasalpolyposis with polyps projecting into or com-pletely occluding the nasal airway (CRS withpolyposis). ... clinicopathological entity.Laryngoscope 2000;110(5 Pt 1):799–813.6. Kennedy DW. Functional endoscopic sinussurgery. Technique. Arch Otolaryngol1985;111:643–9.7. Kennedy DW, Zinreich SJ, Rosenbaum...

... NSAID hypersensitivity on the basis of its inhibitory activity on the newly describedenzyme, cyclooxygenase (COX)-3. This nonspecific sensitivity to inhibition of COX is most likely genetically determined ... anti-inflammatory activity ofthe NSAID is secondary to the COX-2 inhibition, and thisactivity is only marginally relevant to the hypersensitivityreactions elicited, as proven by the relative safety of ... of hypersensitivity reactions to the commonlyused antipyretics in young children is low and urticaria/angiodema, that is, ‘‘only skin deep’’ reactions, maypredominate, respiratory and systemic...

... astryptase and chymase, which interact with many cells andpotentially contribute to airway wall remodelling.6Tumour necrosis factor a (TNF-a) is another proinflam-matory cytokine secreted by ... non-proteolytic actions. Am J Physiol Lung Cell Mol Physiol 2002;282:L197–206.69. Venkayya R, Lam M, Willkom M, et al. The Th2 lymphocyteproducts IL-4 and IL-13 rapidly induce airway hyperresponsive-ness ... dysfunctional airway elements, suggesting thatthe targeted delivery of their mediators is likely to becentral to the disordered airway physiology.Infiltration of the bronchial epithelium by...

... McMasterUniversity, Hamilton, Ontario, Canada.2Departments of Medicine andPhysiology & Pharmacology, Snyder Institute of Infection, Immunity andInflammation, University of Calgary, Calgary, Alberta, ... pressure: Respiratory rate:Pulse: Temperature:Asthma control questionnaireHow many times per week do you have asthma symptoms during the day?How many times per week do you have asthma symptoms at ... themechanism(s) underlying omalizumab-associated ana-phylaxis. There have, however, been several hypothesesproposed. These include a potential pre-existing anti-allotypic or anti-idiotypic antibody (IgE...

... years of pain in thealexithymic and 3,31 ± 2,79 years in the nonalexithymicgroups. Persistency of any physical symptom may bringalong alexithymia as a coping strategy. In their paper,Crook and ... Biological Psychiatry, Berlin, Germany, July 1–6, 2001.References1. Sifneos PE: Short-Term Psychotherapy and Emotional Crisis Cambridge,MA: Harvard University Press; 1972. 2. Taylor GJ, Bagby RM, ... factor analytic study. Psychosomatics 1996, 37(5):451-8.17. Lumley MA, Asselin LA, Norman S: Alexithymia in chronic painpatients. Compr Psyhiatry 1997, 38(3):160-5.18. Lumley MA, Tomakowsky J, Torosian...